Patient Rating:

No Rating Available?

Andrew T. Pavia, M.D.

Chief, Division of Pediatric Infectious Diseases

Specialties

Languages

  • English
  • French
  • Italian

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 581-6791 Primary Children's Hospital
100 N Mario Capecchi Drive
Salt Lake City, UT 84113

Bio

Dr. Pavia received his undergraduate and medical degrees from Brown University. He completed his residency at Dartmouth Hitchcock Medical Center and served as chief resident. He then served as an officer in the Epidemic Intelligence Service at the Centers for Disease Control and Prevention and completed a residency in Preventive Medicine. He completed fellowship training in Pediatric and Adult Infectious Diseases at the University of Utah.

Dr. Pavia is currently the George and Esther Gross Presidential Professor at the University of Utah and is Chief of the Division of Pediatric Infectious Diseases.

His academic interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections and diarrheal diseases. He is also keenly interested in HIV/AIDS and has been involved in HIV clinical care and research since the 1980’s.

Board Certification and Academic Information

Academic Departments Pediatrics - Professor
Internal Medicine - Adjunct Professor
Academic Divisions Infectious Diseases
Pediatric Infectious Diseases
Board Certification American Board of Internal Medicine (Internal Medicine)

Academic Profile

Board Certification and Academic Information

Academic Departments Pediatrics - Professor
Internal Medicine - Adjunct Professor
Academic Divisions Infectious Diseases
Pediatric Infectious Diseases
Board Certification American Board of Internal Medicine (Internal Medicine)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 581-6791 School of Medicine
Pediatric Infectious Diseases
30 N Medical Dr
Salt Lake City, UT 84132
(801) 581-6791 Williams Building
295 Chipeta Way
Salt Lake City, UT 84108

Academic Bio

Dr. Pavia received his B.A and M.D. at Brown University. He trained in Internal Medicine and Pediatrics at Dartmouth and the University of Utah, trained in Public Health Epidemiology as an EIS officer and a Preventive Medicine Resident at the Centers for Disease Control and Prevention and completed an Infectious Disease Fellowship at the University of Utah.

He joined the faculty of the University of Utah in 1991. In 2003 he became the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases where he mentors a dynamic and productive team of young faculty and fellows. He also serves as Director of Hospital Epidemiology at Primary Children's Hospital.

Dr. Pavia is a Member of the Society for Pediatric Research and a Fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. He is a member of the Board of Directors the Infectious Disease Society of America (IDSA) and chair of the Pandemic Influenza Task Force and past Chair of the National and Global Public Policy Committee. He serves as a member of the National Vaccine Advisory Committee and chaired the Vaccine Safety Working Group. He served as a member of the National Biodefense Science Board (NBSB) and chaired the Influenza Working Group and co-chaired the Personal Preparedness Working Group of the NBSB from 2008-2010.

Dr. Pavia has served on several Institute of Medicine Committees including “Antivirals for Pandemic Influenza: Guidance on Developing and Distribution and Dispensing System,” and “Prepositioned Medical Countermeasure for the Public,” and is a frequent consultant for CDC. He is on the editorial board of JAIDS and a reviewer for numerous journals. He has published more than 250 peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts.

His research interests include the epidemiology of influenza and other emerging respiratory infections, vaccine preventable diseases, and HIV/ AIDS, with a particular interest in infections of pregnant women and their children. He has been the principal investigator or co-investigator on grants from the National Institutes of Health and the Centers for Disease Control and Prevention.

Education

Education History

Type School Degree
Fellowship University of Utah School of Medicine
Fellow
Fellowship Centers for Disease Control and Prevention
Epidemiology
Fellow
Residency Centers for Disease Control and Prevention
Preventive Medicine
Resident
Chief Resident Dartmouth College
Internal Medicine
Chief Resident
Residency Dartmouth Medical School
Internal Medicine
Resident
Internship Dartmouth Medical School
Intern
Professional Medical Brown University
Medicine
M.D.
Undergraduate Brown University
Biology
A.B.

Publications

Selected Provider Publications

Journal Article

  1. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09.Shapiro DJ, Hicks LA, Pavia AT, Hersh AL (2014). Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother, 69(1), 234-40.
  2. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.LID - 10.3201/eid2002.130687 [doi]Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, Rubinstein E, Holty JE, Messonnier NE, Smith TL, Pesik N, Treadwell TA, Bower WA (2014). Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.LID - 10.3201/eid2002.130687 [doi]. Emerg Infect Dis, 20(2).
  3. Seasonality of acute otitis media and the role of respiratory viral activity in children.Stockmann C, Ampofo K, Hersh AL, Carleton ST, Korgenski K, Sheng X, Pavia AT, Byington CL (2013). Seasonality of acute otitis media and the role of respiratory viral activity in children. Pediatr Infect Dis J, 32(4), 314-9.
  4. Influenza A(H7N9): from anxiety to preparedness.Pavia AT (2013). Influenza A(H7N9): from anxiety to preparedness. Ann Intern Med, 159(3), 219-20.
  5. Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov.Stockmann C, Sherwin CM, Ampofo K, Hersh AL, Pavia AT, Byington CL, Ward RM, Spigarelli MG (2013). Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov. Int J Antimicrob Agents, 42(2), 161-6.
  6. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.Olarte L, Ampofo K, Stockmann C, Mason EO, Daly JA, Pavia AT, Byington CL (2013). Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics, 132(1), e17-24.
  7. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes.Shakib JH, Korgenski K, Sheng X, Varner MW, Pavia AT, Byington CL (2013). Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr, 163(5), 1422-6.e1-4.
  8. Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah.Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT (2013). Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics, 132(3), 421-8.
  9. Laboratory creation of a highly transmissible H5N1 influenza virus: balancing substantial risks and real benefits.Pavia AT (2012). Laboratory creation of a highly transmissible H5N1 influenza virus: balancing substantial risks and real benefits. Ann Intern Med, 156(6), 463-5.
  10. Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children.Doby EH, Benjamin DK Jr, Blaschke AJ, Ward RM, Pavia AT, Martin PL, Driscoll TA, Cohen-Wolkowiez M, Moran C (2012). Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children. Pediatr Infect Dis J, 31(6), 632-5.
  11. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL (2012). The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J, 31(3), 228-34.
  12. Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010.Stockmann C, Ampofo K, Hersh AL, Blaschke AJ, Kendall BA, Korgenski K, Daly J, Hill HR, Byington CL, Pavia AT (2012). Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clin Infect Dis, 55(4), 479-87.
  13. Costs and infant outcomes after implementation of a care process model for febrile infants.Byington CL, Reynolds CC, Korgenski K, Sheng X, Valentine KJ, Nelson RE, Daly JA, Osguthorpe RJ, James B, Savitz L, Pavia AT, Clark EB (2012). Costs and infant outcomes after implementation of a care process model for febrile infants. Pediatrics, 130(1), e16-24.
  14. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system.LID - S0732-8893(12)00342-2 [pii]LID - 10.1016/j.diagmicrobio.2012.08.013 [doi]Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF, Thatcher SA, Pavia AT, Barney T, Alger GD, Daly JA, Ririe KM, Ota I, Poritz MA (2012). Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system.LID - S0732-8893(12)00342-2 [pii]LID - 10.1016/j.diagmicrobio.2012.08.013 [doi]. Diagn Microbiol Infect Dis.
  15. Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination.Guerra AH, Stockmann C, Pavia AT, Hersh AL, Thorell EA, Weng HY, Korgenski K, Byington CL, Ampofo K (2012). Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination. J Pediatric Infect Dis Soc, 1(4), 268-277.
  16. Public health communication with frontline clinicians during the first wave of the 2009 influenza pandemic.Staes CJ, Wuthrich A, Gesteland P, Allison MA, Leecaster M, Shakib JH, Carter ME, Mallin BM, Mottice S, Rolfs R, Pavia AT, Wallace B, Gundlapalli AV, Samore M, Byington CL (2011). Public health communication with frontline clinicians during the first wave of the 2009 influenza pandemic. J Public Health Manag Pract, 17(1), 36-44.
  17. Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic.Hersh AL, Herigon JC, Ampofo K, Pavia AT, Newland JG (2011). Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic. Pediatr Infect Dis J, 30(10), 895-7.
  18. Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA.Rubach MP, Bender JM, Mottice S, Hanson K, Weng HY, Korgenski K, Daly JA, Pavia AT (2011). Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis, 17(9), 1645-50.
  19. Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.Kendall BA, Dascomb KK, Mehta RR, Mason EO, Ampofo K, Pombo DJ, Pavia AT, Byington CL (2011). Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine, 29(49), 9123-6.
  20. Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.Ampofo K, Pavia AT, Stockmann CR, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Byington CL (2011). Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. Pediatr Infect Dis J, 30(12), 1100-3.
  21. Antibiotic prescribing in ambulatory pediatrics in the United States.Hersh AL, Shapiro DJ, Pavia AT, Shah SS (2011). Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics, 128(6), 1053-61.
  22. The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital through the PCV7 Era.Ampofo K, Pavia AT, Stockmann C, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL (2011). The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital through the PCV7 Era. Pediatr Infect Dis J.
  23. Influenza virus infection in infants less than three months of age.Bender JM, Ampofo K, Gesteland P, Sheng X, Korgenski K, Raines B, Daly JA, Valentine K, Srivastava R, Pavia AT, Byington CL (2010). Influenza virus infection in infants less than three months of age. Pediatr Infect Dis J, 29(1), 6-9.
  24. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah.Byington CL, Hulten KG, Ampofo K, Sheng X, Pavia AT, Blaschke AJ, Pettigrew M, Korgenski K, Daly J, Mason EO (2010). Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol, 48(2), 520-5.
  25. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine.Bender JM, Cox CM, Mottice S, She RC, Korgenski K, Daly JA, Pavia AT (2010). Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clin Infect Dis, 50(7), e41-6.
  26. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah.Ampofo K, Herbener A, Blaschke AJ, Heyrend C, Poritz M, Korgenski K, Rolfs R, Jain S, Carvalho Mda G, Pimenta FC, Daly J, Mason EO, Byington CL, Pavia AT (2010). Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J, 29(10), 905-9.
  27. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children.Bender JM, Ampofo K, Byington CL, Grinsell M, Korgenski K, Daly JA, Mason EO, Pavia AT (2010). Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J, 29(8), 712-6.
  28. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.Couturier BA, Bender JM, Schwarz MA, Pavia AT, Hanson KE, She RC (2010). Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients. Influenza Other Respi Viruses, 4(4), 199-204.
  29. Feasibility of elementary school children's use of hand gel and facemasks during influenza season.Allison MA, Guest-Warnick G, Nelson D, Pavia AT, Srivastava R, Gesteland PH, Rolfs RT, Andersen S, Calame L, Young P, Byington CL (2010). Feasibility of elementary school children's use of hand gel and facemasks during influenza season. Influenza Other Respi Viruses, 4(4), 223-9.
  30. Molecular Analysis Improves Pathogen Identification and Epidemiologic Study of Pediatric Parapneumonic Empyema.Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K (2010). Molecular Analysis Improves Pathogen Identification and Epidemiologic Study of Pediatric Parapneumonic Empyema. Pediatr Infect Dis J.
  31. Parapneumonic empyema deaths during past century, Utah.Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington CL (2009). Parapneumonic empyema deaths during past century, Utah. Emerg Infect Dis, 15(1), 44-8.
  32. Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience.Blaschke AJ, Korgenski EK, Daly JA, LaFleur B, Pavia AT, Byington CL (2009). Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience. Am J Infect Control, 37(6), 435-41.
  33. Adolescent vaccination: recommendations from the National Vaccine Advisory Committee.Stokley S, Freed G, Curtis R, Gordon L, Humiston S, Parnell T, Pavia A, Young A, Johnson D, Kennedy A, Hopfensperger D, Markowitz L, Fergie J, Koslap-Petraco MB, McCauley M (2009). Adolescent vaccination: recommendations from the National Vaccine Advisory Committee. Am J Prev Med, 36(3), 278-9.e6.
  34. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK (2009). Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis, 48(8), 1003-32.
  35. Development and validation of a risk score for predicting hospitalization in children with influenza virus infection.Bender JM, Ampofo K, Gesteland P, Stoddard GJ, Nelson D, Byington CL, Pavia AT, Srivastava R (2009). Development and validation of a risk score for predicting hospitalization in children with influenza virus infection. Pediatr Emerg Care, 25(6), 369-75.
  36. Family clusters of variant X-linked chronic granulomatous disease.Bender JM, Rand TH, Ampofo K, Pavia AT, Schober M, Tebo A, Pasi B, Augustine NH, Pryor RJ, Wittwer CT, Hill HR (2009). Family clusters of variant X-linked chronic granulomatous disease. Pediatr Infect Dis J, 28(6), 529-33.
  37. COCCIDIOIDES IMMITIS MENINGITIS IN A PATIENT WITH HYPERIMMUNOGLOBULIN E SYNDROME DUE TO A NOVEL MUTATION IN SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION.Powers AE, Bender JM, Kumanovics A, Ampofo K, Augustine N, Pavia AT, Hill HR (2009). COCCIDIOIDES IMMITIS MENINGITIS IN A PATIENT WITH HYPERIMMUNOGLOBULIN E SYNDROME DUE TO A NOVEL MUTATION IN SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION. Pediatr Infect Dis J, 28(7), 664-666.
  38. Evidence for a heritable predisposition to death due to influenza.Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA (2008). Evidence for a heritable predisposition to death due to influenza. J Infect Dis, 197(1), 18-24.
  39. Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002.Haddad MB, Porucznik CA, Joyce KE, De AK, Pavia AT, Rolfs RT, Byington CL (2008). Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002. Ann Epidemiol, 18(2), 139-46.
  40. Pneumococcal necrotizing pneumonia in Utah: does serotype matter?Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, Byington CL (2008). Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis, 46(9), 1346-52.
  41. Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses.Byington CL, Bender JM, Ampofo K, Pavia AT, Korgenski K, Daly J, Christenson JC, Adderson E (2008). Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses. Clin Infect Dis, 47(1), e4-6.
  42. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection.Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, Byington CL (2008). Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics, 122(2), 229-37.
  43. Gordonia species: emerging pathogens in pediatric patients that are identified by 16S ribosomal RNA gene sequencing.Blaschke AJ, Bender J, Byington CL, Korgenski K, Daly J, Petti CA, Pavia AT, Ampofo K (2007). Gordonia species: emerging pathogens in pediatric patients that are identified by 16S ribosomal RNA gene sequencing. Clin Infect Dis, 45(4), 483-6.
  44. Informing the front line about common respiratory viral epidemics.Gesteland PH, Samore MH, Pavia AT, Srivastava R, Korgenski K, Gerber K, Daly JA, Mundorff MB, Rolfs RT, James BC, Byington CL (2007). Informing the front line about common respiratory viral epidemics. AMIA Annu Symp Proc, 274-8.
  45. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO (2006). Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J, 25(3), 250-4.
  46. Predictors of fatality in postdiarrheal hemolytic uremic syndrome.Oakes RS, Siegler RL, McReynolds MA, Pysher T, Pavia AT (2006). Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics, 117(5), 1656-62.
  47. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection.Ampofo K, Gesteland PH, Bender J, Mills M, Daly J, Samore M, Byington C, Pavia AT, Srivastava R (2006). Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics, 118(6), 2409-17.
  48. Antiviral management of seasonal and pandemic influenza.Hayden FG, Pavia AT (2006). Antiviral management of seasonal and pandemic influenza. J Infect Dis, 194 Suppl 2, S119-26.
  49. Seasonal and pandemic influenza: recommendations for preparedness in the United States.Whitley RJ, Bartlett J, Hayden FG, Pavia AT, Tapper M, Monto AS (2006). Seasonal and pandemic influenza: recommendations for preparedness in the United States. J Infect Dis, 194 Suppl 2, S155-61.
  50. Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003.Haddad MB, Hill MB, Pavia AT, Green CE, Jumaan AO, De AK, Rolfs RT (2005). Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003. Pediatrics, 115(6), 1488-93.
  51. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT (2005). Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis, 41(1), 21-9.
  52. Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection.Hardin DS, Rice J, Doyle ME, Pavia A (2005). Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection. Clin Endocrinol (Oxf), 63(3), 259-62.
  53. Pediatric invasive fungal rhinosinusitis in immunocompromised children with cancer.Park AH, Muntz HR, Smith ME, Afify Z, Pysher T, Pavia A (2005). Pediatric invasive fungal rhinosinusitis in immunocompromised children with cancer. Otolaryngol Head Neck Surg, 133(3), 411-6.
  54. Adenoviral infections in children: the impact of rapid diagnosis.Rocholl C, Gerber K, Daly J, Pavia AT, Byington CL (2004). Adenoviral infections in children: the impact of rapid diagnosis. Pediatrics, 113(1 Pt 1), e51-6.
  55. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, Levy H, Koster FT, Baum K, Lindemulder A, Wang W, Riser L, Fernandez H, Whitley RJ (2004). Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis, 39(9), 1307-13.
  56. A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, Antunes F, Gulick R, Banhegyi D, van der Valk M, Reiss P, van Weert L, van Leth F, Johnson VA, Sommadossi JP, Lange JM (2003). A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. AIDS, 17(7), 987-99.
  57. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens.Byington CL, Rittichier KK, Bassett KE, Castillo H, Glasgow TS, Daly J, Pavia AT (2003). Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics, 111(5 Pt 1), 964-8.
  58. Clustering of post-diarrheal (Shiga toxin-mediated) hemolytic uremic syndrome in families.Siegler RL, Sherbotie JR, Denkers ND, Pavia AT (2003). Clustering of post-diarrheal (Shiga toxin-mediated) hemolytic uremic syndrome in families. Clin Nephrol, 60(2), 74-9.
  59. Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome.Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, Rollin PE, Baum KF, Pavia AT, Christenson JC, Rubin PJ, Jolson HM, Behrman RE, Khan AS, Bell LJ, Simpson GL, Hawk J, Holman RC, Peters CJ (2002). Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clin Infect Dis, 34(3), 293-304.
  60. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, Kaplan S, Carroll KC, Daly JA, Christenson JC, Samore MH (2002). An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis, 34(4), 434-40.
  61. Cerebral aneurysms in a child with acquired immune deficiency syndrome during rapid immune reconstitution.Bonkowsky JL, Christenson JC, Nixon GW, Pavia AT (2002). Cerebral aneurysms in a child with acquired immune deficiency syndrome during rapid immune reconstitution. J Child Neurol, 17(6), 457-60.
  62. The effect of rapid respiratory viral diagnostic testing on antibiotic use in a children's hospital.Byington CL, Castillo H, Gerber K, Daly JA, Brimley LA, Adams S, Christenson JC, Pavia AT (2002). The effect of rapid respiratory viral diagnostic testing on antibiotic use in a children's hospital. Arch Pediatr Adolesc Med, 156(12), 1230-4.
  63. Recurrent hemolytic uremic syndrome.Siegler RL, Pavia AT, Sherbotie JR (2002). Recurrent hemolytic uremic syndrome. Clin Pediatr (Phila), 41(9), 705-9.
  64. Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?Adderson EE, Byington CL, Spencer L, Kimball A, Hindiyeh M, Carroll K, Mottice S, Korgenski EK, Christenson JC, Pavia AT (2001). Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era? Pediatrics, 108(1), E18.
  65. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.Davey RT Jr, Murphy RL, Graziano FM, Boswell SL, Pavia AT, Cancio M, Nadler JP, Chaitt DG, Dewar RL, Sahner DK, Duliege AM, Capra WB, Leong WP, Giedlin MA, Lane HC, Kahn JO (2000). Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. JAMA, 284(2), 183-9.
  66. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak.Staes CJ, Schlenker TL, Risk I, Cannon KG, Harris H, Pavia AT, Shapiro CN, Bell BP (2000). Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics, 106(4), E54.
  67. Adderson EE, Pavia AT, Christenson JC, Davis R, Leonard RB, Carroll KC (2000). A community pseudo-outbreak of invasive Staphylococcus aureus infection. Diagn Microbiol Infect Dis, 37, 219-21.
  68. Bacillus cereus infections among oncology patients at a children's hospital.Christenson JC, Byington C, Korgenski EK, Adderson EE, Bruggers C, Adams RH, Jenkins E, Hohmann S, Carroll K, Daly JA, Pavia AT (1999). Bacillus cereus infections among oncology patients at a children's hospital. Am J Infect Control, 27(6), 543-6.
  69. Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data.Ioannidis JP, Collier AC, Cooper DA, Corey L, Fiddian AP, Gazzard BG, Griffiths PD, Contopoulos-Ioannidis DG, Lau J, Pavia AT, Saag MS, Spruance SL, Youle MS (1998). Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis, 178(2), 349-59.
  70. Spontaneous intestinal perforation in premature infants: a distinct clinical entity associated with systemic candidiasis.Adderson EE, Pappin A, Pavia AT (1998). Spontaneous intestinal perforation in premature infants: a distinct clinical entity associated with systemic candidiasis. J Pediatr Surg, 33(10), 1463-7.
  71. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.Raboud JM, Montaner JS, Rae S, Kahn J, Hammer SM, Katzenstein DA, Pavia A, Dolin R, Hughes MD, Cross A, Beltangady M, Gatell J, Dunkle L, Smaldone L (1997). Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. Antivir Ther, 2(4), 237-47.
  72. Hemolytic-uremic syndrome in adolescents.Siegler RL, Pavia AT, Cook JB (1997). Hemolytic-uremic syndrome in adolescents. Arch Pediatr Adolesc Med, 151(2), 165-9.
  73. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.Spruance SL, Pavia AT, Mellors JW, Murphy R, Gathe J Jr, Stool E, Jemsek JG, Dellamonica P, Cross A, Dunkle L (1997). Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group. Ann Intern Med, 126(5), 355-63.
  74. Characterization of endemic strains of Shigella sonnei by use of plasmid DNA analysis and pulsed-field gel electrophoresis to detect patterns of transmission.Litwin CM, Leonard RB, Carroll KC, Drummond WK, Pavia AT (1997). Characterization of endemic strains of Shigella sonnei by use of plasmid DNA analysis and pulsed-field gel electrophoresis to detect patterns of transmission. J Infect Dis, 175(4), 864-70.
  75. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir.Meadows KP, Tyring SK, Pavia AT, Rallis TM (1997). Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol, 133(8), 987-90.
  76. The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.Deeks SG, Collier A, Lalezari J, Pavia A, Rodrigue D, Drew WL, Toole J, Jaffe HS, Mulato AS, Lamy PD, Li W, Cherrington JM, Hellmann N, Kahn J (1997). The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. J Infect Dis, 176(6), 1517-23.
  77. Meningitis due to Ochrobactrum anthropi: an emerging nosocomial pathogen. A report of 3 cases.Christenson JC, Pavia AT, Seskin K, Brockmeyer D, Korgenski EK, Jenkins E, Pierce J, Daly JA (1997). Meningitis due to Ochrobactrum anthropi: an emerging nosocomial pathogen. A report of 3 cases. Pediatr Neurosurg, 27(4), 218-21.
  78. Fischer PR, Christenson JC, Pavia AT, Orme GA (1997). Post-operative Mycobacterium flavescens infection in a child. Infect Dis Clin Pract, 6, 263-5.
  79. Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease.Siegler RL, Pavia AT, Hansen FL, Christofferson RD, Cook JB (1996). Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease. J Pediatr, 128(4), 505-11.
  80. Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients.Chang HJ, Christenson JC, Pavia AT, Bobrin BD, Bland LA, Carson LA, Arduino MJ, Verma P, Aguero SM, Carroll K, Jenkins E, Daly JA, Woods ML, Jarvis WR (1996). Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients. J Infect Dis, 173(3), 656-60.
  81. Christenson JC, Pavia AT, Woods ML, Carroll KC, Nichols C (1996). Ochrabactrum anthropi meningitis from cadaveric pericardial dural gafts. MMWR CDC Surveill Summ, 45, 671-673.
  82. Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful?Riley DK, Pavia AT, Beatty PG, Denton D, Carroll KC (1995). Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful? Bone Marrow Transplant, 15(3), 469-73.
  83. Invasive sinonasal disease due to Scopulariopsis candida: case report and review of scopulariopsosis.Kriesel JD, Adderson EE, Gooch WM 3rd, Pavia AT (1994). Invasive sinonasal disease due to Scopulariopsis candida: case report and review of scopulariopsosis. Clin Infect Dis, 19(2), 317-9.
  84. Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group.Spruance SL, Pavia AT, Peterson D, Berry A, Pollard R, Patterson TF, Frank I, Remick SC, Thompson M, MacArthur RD, et al (1994). Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. Ann Intern Med, 120(5), 360-8.
  85. The prophylactic use of low-dose amphotericin B in bone marrow transplant patients.Riley DK, Pavia AT, Beatty PG, Petersen FB, Spruance JL, Stokes R, Evans TG (1994). The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med, 97(6), 509-14.
  86. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah.Siegler RL, Pavia AT, Christofferson RD, Milligan MK (1994). A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics, 94(1), 35-40.
  87. Rocha BHSC, Christenson JC, Pavia AT, Evans RS, Gardner RM (1994). Computerized detection of nosocomial infections in newborns. J Am Med Inform Assoc, S684-S688.
  88. Partner notification for control of HIV: results after 2 years of a statewide program in Utah.Pavia AT, Benyo M, Niler L, Risk I (1993). Partner notification for control of HIV: results after 2 years of a statewide program in Utah. Am J Public Health, 83(10), 1418-24.
  89. Nosocomial Legionella pneumonia in the neonate.Holmberg RE Jr, Pavia AT, Montgomery D, Clark JM, Eggert LD (1993). Nosocomial Legionella pneumonia in the neonate. Pediatrics, 92(3), 450-3.
  90. Effect of dronabinol on nutritional status in HIV infection.Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, Ries K, Evans TG (1993). Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother, 27(7-8), 827-31.
  91. Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: clinical, microbiologic and epidemiologic features.Pavia AT, Long EG, Ryder RW, Nsa W, Puhr ND, Wells JG, Martin P, Tauxe RV, Griffin PM (1992). Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: clinical, microbiologic and epidemiologic features. Pediatr Infect Dis J, 11(12), 996-1003.
  92. Barrett TJ, Green JH, Griffin PM, Pavia AT, Ostroff SM, Wachsmuth IK (1991). Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Sigan-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr Microbiol, 23, 189-195.
  93. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations.Pavia AT, Nichols CR, Green DP, Tauxe RV, Mottice S, Greene KD, Wells JG, Siegler RL, Brewer ED, Hannon D, et al (1990). Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr, 116(4), 544-51.
  94. Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella.Pavia AT, Shipman LD, Wells JG, Puhr ND, Smith JD, McKinley TW, Tauxe RV (1990). Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella. J Infect Dis, 161(2), 255-60.
  95. A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin.Pavia AT, Nielsen L, Armington L, Thurman DJ, Tierney E, Nichols CR (1990). A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin. Am J Epidemiol, 131(6), 1085-93.
  96. Vibrio carchariae infection after a shark bite.Pavia AT, Bryan JA, Maher KL, Hester TR Jr, Farmer JJ 3rd (1989). Vibrio carchariae infection after a shark bite. Ann Intern Med, 111(1), 85-6.
  97. Cholera in Louisiana. Widening spectrum of seafood vehicles.Lowry PW, Pavia AT, McFarland LM, Peltier BH, Barrett TJ, Bradford HB, Quan JM, Lynch J, Mathison JB, Gunn RA, et al (1989). Cholera in Louisiana. Widening spectrum of seafood vehicles. Arch Intern Med, 149(9), 2079-84.
  98. Salmonella isolates from humans in the United States, 1984-1986.Hargrett-Bean NT, Pavia AT, Tauxe RV (1988). Salmonella isolates from humans in the United States, 1984-1986. MMWR CDC Surveill Summ, 37(2), 25-31.
  99. Sex hormones and coronary artery disease.Chute CG, Baron JA, Plymate SR, Kiel DP, Pavia AT, Lozner EC, OKeefe T, MacDonald GJ (1987). Sex hormones and coronary artery disease. Am J Med, 83(5), 853-9.
  100. Pavia AT (1987). Diseases Associated with Raw Oysters. Ga Epidemiol Rep, 3, 1.
  101. Novotny T, Dingman JD, Pavia AT (1987). Foodborne illness associated with a pig roast. J Food Prot, 50, 945-47.
  102. Pavia AT, Tauxe RV (1987). Traveler's Diarrhea and the Soviet Union. JAMA, 258;1661.
  103. Pavia AT (1986). Cholera in Louisiana. MMWR CDC Surveill Summ, 35, 687-8.

Review

  1. What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?Pavia AT (2013). What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia? [Review]. Infect Dis Clin North Am, 27(1), 157-75.
  2. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis.Pavia AT (2011). Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. [Review]. Clin Infect Dis, 52 Suppl 4, S284-9.
  3. End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease.Ison MG, de Jong MD, Gilligan KJ, Higgs ES, Pavia AT, Pierson J, Hayden FG (2010). End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease. [Review]. J Infect Dis, 201(11), 1654-62.
  4. Advances in antimicrobial therapy.Pavia AT (1999). Advances in antimicrobial therapy. [Review]. Seminars in Pediatric Neurology, 6(4), 288-98.
  5. Pavia AT (1994). Approach to food-borne and water-borne illness. [Review]. Seminars in Pediatric Infectious Diseases, 5, 222-230.
  6. A new look at typhoid vaccination. Information for the practicing physician.Woodruff BA, Pavia AT, Blake PA (1991). A new look at typhoid vaccination. Information for the practicing physician. [Review]. JAMA, 265(6), 756-9.

Book Chapter

  1. Doby E, Pavia AT (2012). Managing HIV Infection in Children and Adolescents. In Volberding, Greene, Lange, Gallant and Swankambo (Ed.), Sande's HIV and AIDS Medicine (2nd). London: Elsevier.
  2. Pavia AT (2009). Food Poisoning. In Schlossberg D (Ed.), Current Therapy of Infectious Disease (3). Philadelphia: Mosby-Year Book.
  3. Pavia AT (2009). Food-Borne and Water Borne Disease. In Long SS, Prober CG, Pickering LK (Ed.), Principles and Practice of Pediatric Infectious Diseases (3). New York: Churchill Livingstone.
  4. Blaschke A, Pavia AT (2009). Infectious Diarrhea. In Wilson, Sande, Henry, Drew, Relman, Steckelberg and Gerberding, (Ed.), Current Diagnosis and Treatment of Infectious Diseases, (2). Lange Medical Books/McGraw Hill.
  5. Pavia AT (2009). Managing HIV infection in children and adolescents. In Sande M, Volberding P, Lange J, Greene W (Ed.), Global HIV/AIDS Medicine (1). Elsevier.
  6. Pavia AT, Zar H (2009). Pediatric HIV Infection. In Global AIDS Learning and Evaluation Network (GALEN). International Association of Physicians in AIDS Care (IAPAC).
  7. Pavia AT (2009). Salmonella, Shigella and enteric E. coli infections. In Rudolph C et al (Ed.), Rudolph’s Textbook of Pediatrics (22). New York: McGraw Hill.
  8. Pavia AT (2009). Stavudine. In Dolin RD, Masur H, Saag M (Ed.), AIDS Therapy (3). New York: Churchill Livingston.
  9. Pavia AT (2003). Infants and Children. In Cohen PT, Sande MA, Volberding PA (Ed.), The AIDS Knowledge Base (4th). Lippincott, Williams, & Wilkins.
  10. Pavia AT (2003). Stavudine. In Dolin RD, Masur H, Saag M (Ed.), AIDS Therapy (2nd). Churchill Livingston.
  11. Pavia AT (2002). Evaluation of the returned traveller: Diarrhea and foodborne illness. In Armstong D and Cohen J (Ed.), Infectious Diseases (2nd). London: Mosby Inc.
  12. Pavia AT (2002). Salmonella, Shigella and enteric E. coli infections. In Rudolph A et al (Ed.), Rudolph's Textbook of Pediatrics.
  13. Pavia AT (2001). Food-Borne and Water Borne Disease. In Long SS, Prober CG, Pickering LK (Ed.), Principles and Practice of Pediatric Infectious Diseases (2nd). New York: Churchill Livingstone.
  14. Fischer PR, Christenson JC, Pavia AT (1999). Evaluation of the child returning from travel to a developing country. In Bia F (Ed.), Travel Medicine Advisor.
  15. Pavia AT (1999). Evaluation of the returned traveller: Diarrhea and foodborne illness. In Armstrong D and Cohen J (Ed.), Infectious Diseases. London: Mosby Inc.
  16. Pavia AT (1999). Food Poisoning. In Schlossberg D (Ed.), Current Therapy of Infectious Disease Second Edition. Philadelphia: Mosby-Year Book Inc.
  17. Pavia AT, Christenson JC (1999). Pediatric AIDS. In Sande MA, Volberding PA (Ed.), The Medical Management of AIDS (6th).
  18. Pavia AT (1999). Stavudine. In Dolin RD, Masur H, Saag M (Ed.), AIDS Therapy. New York: Churchill Livingston, Inc.
  19. Tauxe RV, Pavia AT (1998). Salmonellosis: Nontyphoidal. In Evans A and Brachman P (Ed.), Bacterial Infections in Humans (3rd). New York: Plenum.
  20. Pavia AT (1997). Food Poisoning. In Kassirer JP, Greene HL (Ed.), Current Therapy in Adult Medicine. Philadelphia: Mosby-Year Book Inc.
  21. Pavia AT (1996). Food-Borne and Water Borne Disease. In Long SS, Prober CG, Pickering LK (Ed.), Principles and Practice of Pediatric Infectious Diseases (1st). New York: Churchill Livingstone.
  22. Pavia AT (1995). Food Poisoning. In Schlossberg D (Ed.), Current Therapy of Infectious Disease. Philadelphia: Mosby-Year Book Inc.
  23. Pavia AT, Siegler RL, Christofferson R, Milligan M (1994). A 20-Year Population-Based Study of Hemolytic Uremic Syndrome: Evidence for the Importance of Shiga-Like Toxin Producting Escherichia coli. In Karmali MA, Goglio AG (Ed.), Recent Advances in Verocytotoxin-Producing Escherichia coli Infections (pp. 25-28). Amsterdam: Elsevier Science.
  24. Pavia AT, Tauxe RV (1991). Salmonellosis. In Kelley WN (Ed.), Textbook of Internal Medicine (2nd). Philadelphia: JB Lippincott Co.
  25. Pavia AT, Tauxe RV (1991). Salmonellosis: Nontyphoidal. In Evans A and Brachman P (Ed.), Bacterial Infections in Humans (2nd). New York: Plenum.
  26. Pavia AT, Lowry PW, McFarland L, Bradford HB, Cook WL, Wachsmuth IK, Blake PA (1987). Cholera in the United States 1986: The Widening Spectrum. In Advances in Research on Cholera and Related Diarrheas: Proceedings of the Twenty-Third Joint Cholera Conference 1987. Tokyo: KTK Publishers.

Case Report

  1. Bartonella vinsonii endocarditis in an adolescent with congenital heart disease.Olarte L, Ampofo K, Thorell EA, Sanderson S, Doby E, Pavia AT, Rosado H, Raoult D, Socolovschi C, Hersh AL (2012). Bartonella vinsonii endocarditis in an adolescent with congenital heart disease. Pediatr Infect Dis J, 31(5), 531-4.
  2. Possible intrafamilial transmission of Toxocara causing eosinophilic meningitis in an infant.Keller M, Pavia AT, Byington CL (2008). Possible intrafamilial transmission of Toxocara causing eosinophilic meningitis in an infant. Pediatr Infect Dis J, 27(9), 849-50.

Editorial

  1. N95 respirators or surgical masks to protect healthcare workers against respiratory infections: are we there yet?Bessesen MT, Savor-Price C, Simberkoff M, Reich NG, Pavia AT, Radonovich LJ (2013). N95 respirators or surgical masks to protect healthcare workers against respiratory infections: are we there yet? Am J Respir Crit Care Med, 187(9), 904-5.
  2. Editorial commentary: What did we learn from the emergency use authorization of peramivir in 2009?Pavia AT (2012). Editorial commentary: What did we learn from the emergency use authorization of peramivir in 2009? Clin Infect Dis, 55(1), 16-8.
  3. Editors' introduction: Vaccine safety throughout the product life cycle.Salmon DA, Pavia A, Gellin B (2011). Editors' introduction: Vaccine safety throughout the product life cycle. Pediatrics, 127 Suppl 1, S1-4.
  4. Mandate to protect patients from health care-associated influenza.Pavia AT (2010). Mandate to protect patients from health care-associated influenza. Clin Infect Dis, 50(4), 465-7.
  5. Germs on a plane: aircraft, international travel, and the global spread of disease.Pavia AT (2007). Germs on a plane: aircraft, international travel, and the global spread of disease. J Infect Dis, 195(5), 621-2.
  6. Editorial comment: fixed-dose combination formulations are the answer, what was the question?Pavia AT (2004). Editorial comment: fixed-dose combination formulations are the answer, what was the question? AIDS Read, 14(10), 549.
  7. Is the concept, "agents of sexually transmitted disease" still valid?McGee ZA, Pavia AT (1991). Is the concept, "agents of sexually transmitted disease" still valid? Sex Transm Dis, 18(2), 69-71.

Letter

  1. Species-specific PCR improves detection of bacterial pathogens in parapneumonic empyema compared with 16S PCR and culture.Blaschke AJ, Byington CL, Ampofo K, Pavia AT, Heyrend C, Rankin SC, McGowan KL, Harris MC, Shah SS (2013). Species-specific PCR improves detection of bacterial pathogens in parapneumonic empyema compared with 16S PCR and culture [Letter to the editor]. Pediatr Infect Dis J, 32(3), 302-3.
  2. Cerebral vasculopathy with aneurysm formation in HIV-infected young adults.Bonkowsky J, Pavia A (2007). Cerebral vasculopathy with aneurysm formation in HIV-infected young adults [Letter to the editor]. Neurology, 68(8), 623; author reply 623.
  3. Fluconazole prophylaxis in patients with leukemia.Pavia AT, Riley DK (1993). Fluconazole prophylaxis in patients with leukemia [Letter to the editor]. Ann Intern Med, 119(9), 951-2.
  4. Cholera from raw oysters shipped interstate.Pavia AT, Campbell JF, Blake PA, Smith JD, McKinley TW, Martin DL (1987). Cholera from raw oysters shipped interstate [Letter to the editor]. JAMA, 258(17), 2374.
  5. Pavia AT (1986). Salmonellosis in a School System [Letter to the editor]. MMWR CDC Surveill Summ, 36, 74-75.

Other

  1. Pavia AT (1989). Legionella: Review of a Continuing Nosocomial Problem. Rocky Mountain Infection Control Bulletin.

Poster

  1. Pavia AT (1985). Sex Hormones, Lipids, and Coronary Artery Disease.

Clinical Trials

Video & News